OXB Company Bio
Oxford Biomedica is one of the original pioneers in gene and cell therapy. We’re already collaborating with some of the world’s most innovative pharmaceutical and biotechnology companies towards a shared mission: to make cell and gene therapy a universally accessible clinical option.
We are a global quality and innovation-led CDMO with over 25 years of experience, committed to helping our clients deliver cell and gene therapies that transform patients’ lives.
We offer end-to-end capabilities to our clients all around the world from our sites in UK, USA and France. We go from plasmid design and optimisation to clinical and commercial GMP manufacturing, accompanied by robust control systems, analytical methods and deep regulatory knowledge. Our clients us our products at commercial scale in more than 40 countries.
Our expertise across lentivirus, AAV, and adenoviral vectors is relied upon by some of the world’s most successful biotechnology and pharmaceutical companies.